EQS-Adhoc

    101 Aufrufe 101 0 Kommentare 0 Kommentare

    Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

    Für Sie zusammengefasst
    • Marinomed Biotech AG enters court restructuring process.
    • Trading of shares expected to resume soon on Vienna Stock.
    • Proceedings initiated without self-administration by court.

    EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
    Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

    14-Aug-2024 / 15:35 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.

    Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange. 

    +++ End of ad-hoc announcement +++ 


    End of Inside Information

    14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com
    Language: English
    Company: Marinomed Biotech AG
    Hovengasse 25
    2100 Korneuburg
    Austria
    Phone: +43 2262 90300
    E-mail: office@marinomed.com
    Internet: www.marinomed.com
    ISIN: ATMARINOMED6
    WKN: A2N9MM
    Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market)
    EQS News ID: 1968247

     
    End of Announcement EQS News Service

    1968247  14-Aug-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=1968247&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e 

    Diskutieren Sie über die enthaltenen Werte


    EQS Group AG
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Verfasst von EQS Group AG
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    EQS-Adhoc Marinomed Biotech AG: Court opens restructuring proceedings without self-administration EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company Marinomed Biotech AG: Court opens restructuring proceedings without self-administration 14-Aug-2024 / 15:35 CET/CEST Disclosure of an inside information acc. to …